Graphex Group Ltd. Files November 2024 6-K Report

TL;DR

Graphex Group Ltd. (GRPH) filed its monthly 6-K report on 11/18/24, no major news.

AI Summary

Graphex Group Ltd. filed a Form 6-K on November 18, 2024, reporting for the month of November 2024. The company, formerly known as Earthasia International Holdings Ltd. until July 2, 2020, is incorporated in E9 and has its principal executive offices in Hong Kong. This filing is made under the 1934 Securities Exchange Act.

Why It Matters

This filing provides routine updates for investors and regulatory bodies regarding Graphex Group Ltd.'s ongoing compliance and reporting requirements as a foreign private issuer.

Risk Assessment

Risk Level: low — This filing is a routine report and does not contain significant new financial information or strategic changes.

Key Numbers

• 001-41471 — SEC File Number (Identifies the company's registration with the SEC.)
• 20241118 — Filing Date (Indicates when the report was submitted to the SEC.)

Key Players & Entities

• Graphex Group Ltd. (company) — Registrant
• Earthasia International Holdings Ltd. (company) — Former company name
• 001-41471 (dollar_amount) — SEC File Number
• 20200702 (dollar_amount) — Date of name change
• 20241118 (dollar_amount) — Filing date

FAQ

Filing Documents

• form6-k.htm (6-K) — 31KB
• ex99-1.htm (EX-99.1) — 10KB
• ex99-1_001.jpg (GRAPHIC) — 18KB
• 0001493152-24-046418.txt ( ) — 66KB

Signatures

Signatures 3 Exhibit Index 4 Other Information Graphex Group Limited (NYSE American: GRFX | HKSE: 6128). Graphex Group Limited (the “Company” or “we”) is an issuer with its ordinary shares listed on The Stock Exchange of Hong Kong Limited (“HKSE”) and has its American Depositary Shares (ADSs) listed on the NYSE American LLC (the “Exchange”) under the symbol “GRFX”. The Company is not in compliance with Sections 134 and 1101 of the NYSE American Company Guide (“Company Guide”) since it failed to timely file with the Securities and Exchange Commission (“SEC”) its Form 20-F for the year ended December 31, 2023 (the “Delayed Filing”). The initial cure period for the Company to maintain its listing of its ADSs listed on the Exchange expired on November 15, 2024. The Exchange has granted the Company’s request to extend the period (“Additional Cure Period”) to complete its Delayed Filing and any subsequently delayed filings with the SEC to May 15, 2025 (the “New Cure Deadline”). The Company has previously provided its 2023 annual report that included annual financial statements prepared on the basis of Hong Kong dollar and prepared in accordance with International Financial Reporting Standards (“IFRS”) and audited by Crowe (HK) CPA Limited. The Company plans to file the Delayed Filing as soon as possible and in any event within the Additional Cure Period. However, there can be no assurance that the Company will ultimately regain compliance with all applicable Exchange listing standards. The listing of the ADSs continues on the Exchange during the Additional Cure Period pursuant to this extension, subject to the Company’s compliance with other continued listing requirements and the NYSE Regulation Staff’s review of the Company’s efforts to regain compliance with the Exchange’s continued listing stand

Forward Looking Statements

Forward Looking Statements All statements contained in this presentation other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans and our objectives for future operations, are “forward looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and the safe harbor in Section 27A and 21E of the Securities Act of 1933 and the Securities Exchange act of 1934, respectively. You can identify some of these forward looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “likely,” “potential,” “continue” or other similar expressions. We have based these forward looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short term and long-term business operations and objectives, and financial needs. These forward looking statements involve various risks and uncertainties. -2-

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GRAPHEX GROUP LIMTED By: /s/ Andross Chan Andross Chan Chief Executive Officer Date: November 18, 2024 -3- EXHIBIT INDEX Exhibit No. Exhibit 99.1 Company Press Release in the United States. -4-

View Full Filing

View this 6-K filing on SEC EDGAR